Bruker
Bruker Receives CE-IVD Mark for Newly Launched SARS-CoV-2 PCR Test
The FluoroType SARS-CoV-2 varID Q assay detects and quantifies virus levels while also detecting four major virus mutations to aid strain identification.
Bruker Posts 31 Percent Jump in Q1 Revenues
Total revenues rose to $554.7 million from $424.0 million in the first quarter of 2020, beating analysts' consensus estimate of $513.1 million.
Bruker Reports Preliminary Q1 Revenues of $549M to $554M, Beating Analyst Expectations
The company said the performance was driven by double-digit organic year-over-year revenue growth across all three of its Bruker Scientific Instrument groups.
The Bruker-backed startup will make technology whose data could be complementary to both NGS-based Hi-C assays and spatial transcriptomics methods.
Bruker Invests in Startup Acuity Spatial Genomics
Acuity has licensed technology developed in Ting Wu's Harvard lab and will focus on methods to analyze genomic architecture in situ and in 3D.
Mar 10, 2021
Feb 16, 2021
Bruker Q4 Revenues up 5 Percent
Dec 3, 2020
Sep 25, 2020
Sep 11, 2020
Bruker Acquires Canopy Biosciences
Aug 3, 2020
Bruker Posts 13 Percent Decline in Q2 Revenues
Jul 16, 2020
Jun 12, 2020
May 7, 2020